VCYT - Veracyte, Inc.
NEXT EARNINGS:
Feb 25, 2026
(today)
EPS Est: $0.41
|
Rev Est: $135.8M
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$47.25
DETAILS
HIGH:
$50.00
LOW:
$43.00
MEDIAN:
$48.00
CONSENSUS:
$47.25
UPSIDE:
32.39%
Market Cap:
2.82B
Volume:
817,462
Avg Volume:
823,478
52 Week Range:
22.61-50.71
Sector:
Healthcare
Industry:
Biotechnology
Beta:
1.91
Last Dividend:
$N/A
Exchange:
NASDAQ
Country:
US
Employees:
824
IPO Date:
2013-10-30
EPS (TTM):
0.32
P/E Ratio:
125.48
Revenue (TTM):
445.76M
Total Assets:
1.30B
Total Debt:
50.74M
Cash & Equiv:
239.09M
Rev Growth (5Y):
29.9%
EPS Growth (5Y):
N/A
FCF Growth (5Y):
N/A
ROCE:
2.1%
Debt/Equity:
0.04
Earnings History
| Date | EPS Actual | EPS Est | EPS Surprise | Rev Actual | Rev Est | Rev Surprise |
|---|---|---|---|---|---|---|
| 2025-11-04 | $0.51 | $0.32 | +59.4% | $131.9M | $135.8M | -2.9% |
| 2025-08-06 | $0.44 | $0.31 | +41.9% | $130.2M | $124.4M | +4.7% |
| 2025-05-07 | $0.31 | $0.20 | +55.0% | $114.5M | $111.0M | +3.2% |
| 2025-02-24 | $0.36 | $0.10 | +260.0% | $118.6M | $110.7M | +7.1% |
| 2024-11-06 | $0.19 | $0.03 | +603.7% | $115.9M | $116.7M | -0.7% |
| 2024-08-06 | $0.30 | $0.05 | +530.8% | $114.4M | $100.3M | +14.1% |
| 2024-05-07 | $-0.02 | $-0.19 | +89.5% | $96.8M | $93.4M | +3.7% |
| 2024-02-22 | $-0.04 | $-0.07 | +42.9% | $98.2M | $92.0M | +6.8% |
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 445.76M | 361.05M | 296.54M | 219.51M | 117.48M | 120.37M | 92.01M | 71.95M | 65.08M | 49.50M | 38.19M | 21.88M |
| Net Income | 24.14M | (74.40M) | (36.56M) | (75.56M) | (34.91M) | (12.60M) | (23.00M) | (31.00M) | (31.36M) | (33.70M) | (29.37M) | (25.58M) |
| EPS | 0.32 | -1.02 | -0.51 | -1.11 | -0.66 | -0.27 | -0.62 | -0.91 | -1.09 | -1.30 | -1.36 | -6.15 |
| Total Assets | 1.30B | 1.11B | 1.16B | 1.19B | 457.16M | 275.21M | 120.64M | 78.67M | 101.03M | 75.28M | 64.84M | 79.63M |
| Total Debt | 50.74M | 12.63M | 14.72M | 18.85M | 12.32M | 13.61M | 25.28M | 25.25M | 25.52M | 5.03M | 4.92M | 4.90M |
| Cash & Equivalents | 239.09M | 216.45M | 154.25M | 173.20M | 349.36M | 159.32M | 78.00M | 33.89M | 59.22M | 39.08M | 35.01M | 71.22M |
| Operating Cash Flow | 75.10M | 44.22M | 7.54M | (31.62M) | (9.71M) | (3.23M) | (13.52M) | (23.91M) | (27.98M) | (26.96M) | (27.63M) | (19.16M) |
| Free Cash Flow | 63.81M | 34.26M | (1.01M) | (37.00M) | (12.55M) | (5.99M) | (15.39M) | (25.67M) | (32.19M) | (33.13M) | (29.66M) | (20.49M) |
| FCF per Share | 0.83 | 0.47 | -0.01 | -0.54 | -0.24 | -0.13 | -0.42 | -0.76 | -1.12 | -1.28 | -1.37 | -4.93 |
| Book Value | 1.18B | 1.04B | 1.08B | 1.10B | 421.23M | 239.46M | 79.75M | 37.23M | 59.58M | 51.25M | 41.37M | 56.44M |
| Cash & ST Investments | 289.44M | 216.45M | 178.85M | 177.16M | 349.36M | 159.32M | 78.00M | 33.89M | 59.22M | 39.08M | 35.01M | 71.22M |
| ROC Equity | 0.02 | -0.07 | -0.03 | -0.07 | -0.08 | -0.05 | -0.29 | -0.83 | -0.53 | -0.66 | -0.71 | -0.45 |